Clinical Trial Update: HSK7653 in Chinese Patients with Impaired Glucose Tolerance [Phase 2]

View source ↗

Summary

This update reports that the Phase 2 trial of HSK7653 in Chinese patients with impaired glucose tolerance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance

Drugs mentioned

• HSK7653

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Impaired Glucose Tolerance | Phase 2 | Status: COMPLETED